A human trail of Allium fistulosum L. root · Avena sativa L. mixtures on improvement of child height growth

A 24 weeks, multi-center, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Allium fistulosum L. root · Avena sativa L. mixtures on improvement of child height growth

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009726

Enrollment

160

Registered

2024-08-23

Start date

2024-04-03

Completion date

Unknown

Last updated

2024-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : • Allium fistulosum L. root · Avena sativa L. mixtures group: once a day, 1 pack once, after dinnerfor, a duration of 24 weeks(3 g/day, 1.2 g/day for Allium fistulosum L. root ·

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)men and women aged 6 years or older and 8 years or less at the screening test 2) Children before adolescence, 3~ 50 percentile based on Korea standard growth chart percentile 3) Spontaneously agreed to participate in the study by the patients and legal guardians or parents

Exclusion criteria

Exclusion criteria: 1) Participants who have taken Hormone replacement therapy or calcitonin, Phosphonate, growth hormone within 6 month prior to the screening examination 2) Participants with precocious puberty 3) Participants who have started menstruation 4) Participants with a clinically significant disease requiring treatment (i.e., acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.) 5) Participants who take medicine or health functional food for improvement of child height growth within 3 month prior to the screening examination 6) Participants with a history of antipsychotic medication use within 3 months prior to the screening examination 7) Participantts who have participated in other clinical trials within 3 months prior to the screening examination 8) Participants who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes

Design outcomes

Primary

Measure	Time frame
Height	—

Secondary

Measure	Time frame
Rate of growth, Height SDS;growth regulation indicators;bone related indicators;growth related Z-score	—

Countries

Korea, Republic of

Contacts

Public ContactJoo Jongcheon

Wonkwang University Oriental Medical Hospital, Jeonju

jcjoo2000@hanmail.net+82-63-270-1073

Outcome results